Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00331279 · ClinicalTrials.gov registry record · Phase 1
The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: A Pilot Study
A Phase 1 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00331279 is a Phase 1 study that has completed, run by Columbia University. The registered enrollment target is 1 participants.
The verdict
NCT00331279, a Phase 1 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether oral cinnamon extract are effective in reducing insulin resistance parameters in women with polycystic ovary syndrome.
Interventions
- DRUG Placebo
- DRUG Oral Cinnamon Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00331279
The ClinicalTrials.gov registry entry for NCT00331279 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00331279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00331279 about?
NCT00331279 is a clinical study titled "The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: A Pilot Study". The purpose of this study is to determine whether oral cinnamon extract are effective in reducing insulin resistance parameters in women with polycystic ovary syndrome.
What is the current status of trial NCT00331279?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2005-08. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00331279?
The interventions under investigation include: Placebo (DRUG), Oral Cinnamon Extract (DRUG).
Who is sponsoring clinical trial NCT00331279?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.